Amgen (Australia)

Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor

Russell L. Basser, Elizabeth O’Flaherty, Michael Green et al. · Blood · 2002 · 245 citations

A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis

JC Biggs, ST Milliken, Alice K. Fuller et al. · Bone Marrow Transplantation · 1998 · 96 citations

Rheumatoid Disorder, Rheumatology, Rheumatic Diseases +6

Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029

Clara Marquina, Stella Talic, Sandra Vargas-Torres et al. · European Journal of Preventive Cardiology · 2021 · 68 citations

Enhanced Levels and Enhanced Clonogenic Capacity of Blood Progenitor Cells Following Administration of Stem Cell Factor Plus Granulocyte Colony-Stimulating Factor to Humans

C. Glenn Begley, R. Basser, Rachel Mansfield et al. · Blood · 1997 · 59 citations · Full text

Alignment of preferences in the treatment of multiple myeloma – a discrete choice experiment of patient, carer, physician, and nurse preferences

Simon Fifer, Kerrie-Anne Ho, Sean Lybrand et al. · BMC Cancer · 2020 · 51 citations · Full text